Sequenom Shares Fall After Revised Test Data | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Sequenom fell around 10 percent in Wednesday trade, a day after the firm released additional data from a study on its prenatal screening technology for Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.